Sulflux KP-05
by Kaneka Pharma America Corp.
Sulflux KP-05 is an apheresis system filter (FDA unclassified) made by Kaneka Pharma America Corp., listed in FDA GUDID since 17 Dec 2014 (UDI-DI 04537693900639), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number04537693900639 | Date17 Dec 2014 | StatusListed |
Official records
- AccessGUDID record 04537693900639
From the FDA record
- Device description
- Indications for FH: The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma. Indications for FSGS: The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Sulflux
- Generic name
- Apheresis system filter, whole blood
- Model / reference
- KP-05
- Primary DI / UDI-DI
- 04537693900639
- FDA product code
- PBN, MMY
- GMDN term
- Apheresis system filter, whole blood
- Device class
- Unclassified
- GUDID distribution status
- In Commercial Distribution